PURPOSE: Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment, which can be treated surgically by relaxing retinectomy. In this study, we describe patients with severe inferior retinal folding after this surgical intervention (SIRF). METHODS: A retrospective review of the electronic patient records of 254 patients who received relaxing retinectomies was performed to identify patients with SIRF. RESULTS: Five patients (1.97% of those with retinectomy) were identified with SIRF, mean age, 51.4 years; mean follow-up, 36 months. Three patients had rhegmatogenous retinal detachment (RRD) with PVR, one had a dropped nucleus with RRD and PVR and one with giant retinal dialysis from ocular trauma. SIRF was noted from a mean 4.2 months after the retinectomy. All involved the macula and visions were hand movements or perception of light. CONCLUSIONS: SIRF is an uncommon but devastating complication of relaxing retinectomy with a poor visual outcome. This is the first description of this condition that we are aware of.
PURPOSE:Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment, which can be treated surgically by relaxing retinectomy. In this study, we describe patients with severe inferior retinal folding after this surgical intervention (SIRF). METHODS: A retrospective review of the electronic patient records of 254 patients who received relaxing retinectomies was performed to identify patients with SIRF. RESULTS: Five patients (1.97% of those with retinectomy) were identified with SIRF, mean age, 51.4 years; mean follow-up, 36 months. Three patients had rhegmatogenous retinal detachment (RRD) with PVR, one had a dropped nucleus with RRD and PVR and one with giant retinal dialysis from ocular trauma. SIRF was noted from a mean 4.2 months after the retinectomy. All involved the macula and visions were hand movements or perception of light. CONCLUSIONS: SIRF is an uncommon but devastating complication of relaxing retinectomy with a poor visual outcome. This is the first description of this condition that we are aware of.
Authors: Marc Veckeneer; Kristel Maaijwee; David G Charteris; Jan C van Meurs Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-03-18 Impact factor: 3.117